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DSUMMARY
The confluence of obesity and diabetes as a world-
wide epidemic necessitates the discovery of new
therapies. Success in this endeavor requires trans-
latable preclinical studies, which traditionally employ
rodent models. As an alternative approach, we ex-
plored hibernation where obesity is a natural adap-
tation to survive months of fasting. Here we report
that grizzly bears exhibit seasonal tripartite insulin
responsiveness such that obese animals augment
insulin sensitivity but only weeks later enter hiberna-
tion-specific insulin resistance (IR) and subsequently
reinitiate responsiveness upon awakening. Prepara-
tion for hibernation is characterized by adiposity
coupled to increased insulin sensitivity via modified
PTEN/AKT signaling specifically in adipose tissue,
suggesting a state of ‘‘healthy’’ obesity analogous
to humans with PTEN haploinsufficiency. Collec-
tively, we show that bears reversibly cope with ho-
meostatic perturbations considered detrimental to
humans and describe a mechanism whereby IR
functions not as a late-stage metabolic adaptation
to obesity, but rather a gatekeeper of the fed-fasting
transition.
INTRODUCTION
The World Health Organization has proclaimed that obesity may
replace more traditional public maladies, such as undernutrition,
as themost significant cause of poor human health (Fauci, 2008).
However, only three antiobesity drugs are currently marketed
(Yanovski and Yanovski, 2014), despite numerous preclinical
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search models (Vickers et al., 2011). An alternative approach
uses natural extreme biology where evolutionary experimenta-
tion has solved complex physiological problems (Rowe et al.,
2013; Seifert et al., 2012; Smith et al., 2011; Tian et al., 2013;
Tøien et al., 2011). For example, hibernating animals annually
become obese to survive prolonged periods of sparse food
availability.
Hibernation is an astonishing feat of evolution. Following a
period of unparalleled hyperphagia and weight gain, bears do
not eat for up to 7 months and subsist solely on stored fat
while in a hypometabolic state near normal body temperature
(Tøien et al., 2011). Preparation for hibernation centers on
considerable fat accumulation, which necessitates a lipogenic
state. In contrast, prolonged fasting during the winter months
is overcome by utilization of stored lipids via lipolysis (Nelson,
1973). How these annual physiological adaptations—hyperpha-
gia, obesity, and lipolysis—are controlled is unknown. We
decided to study the metabolic consequences of these extreme
states in the grizzly bear (Ursus arctos horribilis).
CRESULTS AND DISCUSSION
Grizzly bears were housed and studied in October (prehiber-
nation), January (hibernation), and May (posthibernation) as
described (Nelson and Robbins, 2010). We utilized bears of var-
iable ages and sex to determine if the physiological responses
observed were broadly relevant or specific to a subset of bears.
In addition, for serum insulin measurements, we used four fe-
male bears that were born in captivity and trained to undergo
sample collection without the potentially confounding effects of
anesthesia. Preparation for hibernation was characterized by
striking increases in body weight and fat (Table 1). We sought
to determine if these alterations were accompanied bymetabolic
adaptations typically found in obese humans. Seasonal changes.
Table 1. Seasonal Body Weights and Percent Body Fat of Bears Used during These Studies
Bear Sex Age (years)
May Body
Weight (kg)
October Body
Weight (kg)
Body Weight
Increase (%)
May Body
Fat (%)
October Body
Fat (%)
Body Fat
Increase (%)
1 M 10 234.1 302.1 29.0 21.1 33.1 56.9
2 M 10 269.5 328.2 21.8 25.7 34.6 34.6
3 F 9 140.4 186.6 32.9 27.5 39.2 42.6
4 F 9 143.9 212.7 47.8 16.6 36.3 118.7
5 M 2 90.2 135.5 50.2 14.6 26.8 83.6
6 M 2 94.5 145.5 54.0 13.4 26.2 95.5
M, male; F, female. D
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Seasonal Insulin Responsiveness in Bearsin key insulin signaling intermediates were observed in adipose
tissue (Figure 1A), liver (Figure 1B), and skeletal muscle (Fig-
ure 1C). Specifically, tissue from obese bears in October con-
tained observable levels of insulin pathway phosphoproteins,
while hibernation was characterized by a complete shutdown
of insulin signaling in both the fasted and insulin-challenged
(Figures 1D and S1, available online) states. Upon awakening
in May, phosphorylation of these pathway components was
again evident, indicating reinitiation of insulin signaling. Interest-
ingly, adipose insulin signaling exhibited augmented levels of
phosphorylated GSK3b, AKT, PTEN, and TSC2 in October.
Therefore, grizzly bear tissues exhibit three distinct states of in-
sulin pathway activation.
We initially assumed that loss of insulin pathway activation
during hibernation was due to prolonged fasting-induced hypo-
insulinemia (Cahill, 1970). Contrary to our expectations, neither
insulin levels nor activity changed between the three experi-
mental periods (Figures 2A and 2B; also see Kamine et al.,
2012). Also, as previously reported (Kamine et al., 2012), blood
glucose levels were unaltered (Figure 2C). The variant nature of
insulin pathway activation in the face of normoinsulinemia sug-
gests that bears are differentially responsive to insulin. To
directly address this, we performed insulin tolerance tests
(ITTs). Interestingly, obese bears were strikingly insulin sensitive
in October (Figure 2D), consistent with the hyperactive state of
insulin signaling (Figure 1A). Remarkably, the bears became in-
sulin resistant only weeks later during hibernation and reverted
to an insulin-responsive state again in May. Levels of serum
nonesterified fatty acids (NEFA) (Saloranta and Groop, 1996)
and adiponectin (Kadowaki et al., 2006) supported the state of
augmented insulin sensitivity in prehibernation obese bears (Fig-
ures 2E and 2F). Collectively, these data demonstrate that grizzly
bears mediate states of reversible insulin responsiveness.
Since insulin resistant bears are euglycemic, we explored why
and how adipose insulin signaling is modulated. Apart from con-
trolling glycemia, insulin potently inhibits adipose tissue lipolysis
(Dimitriadis et al., 2011), a multistep process driving hydrolysis of
triglycerides to glycerol and free fatty acids. Serum from hiber-
nating bears contained significantly more glycerol (Figure 3A),
indicative of active lipolysis. Adipose triglyceride lipase (ATGL)
is responsible for most triacylglycerol breakdown, while the ma-
jor diacylglyceride lipase in adipocytes is hormone-sensitive
lipase (HSL; Zechner et al., 2009). Adipose tissue from hibernat-
ing bears contained increased levels of activated HSL (pHSL;
Figure 3B). Interestingly, levels of pHSL correlated negatively
with phosphorylated AKT, a marker of insulin sensitivity (Toma´s
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lisch and Fasshauer, 2013). Thus, hibernation is accompanied by
loss of insulin pathway activation, normal insulin levels, insulin
resistance, and increased lipolysis.
Obesity is often accompanied by inflammation (van Greeven-
broek et al., 2013; Wei et al., 2008). Despite adiposity and IR,
overt histological changes in either skeletal muscle (Figure 3C)
or liver (Figure 3D) were not observed. However, adipocytes
were noticeably larger in both the insulin-sensitive (October)
and -resistant (January) obese states (Figure 3E), consistent
with the finding that hypertrophic adipocytes predict type 2
diabetes independent of IR (Weyer et al., 2000). No seasonal dif-
ferences in hepatic glycogen content were evident (Figure 3F),
supporting the report that bears selectively store fuel for hiberna-
tion as fat (Hilderbrand et al., 1999). Finally, a lack of systemic
inflammation was indicated by equal levels of circulating cyto-
kines between the obese, hibernating, and posthibernating pe-
riods (Figure 3G). Taken together, these data demonstrate that
obesity and IR in bears is not accompanied by histological
changes typically found in rodents and humans. Further, grizzly
bears preparing for hibernation seemingly store fuel needed for
prolonged fasting selectively in adipose tissue and modulate
insulin responsiveness by tripartite control over insulin signaling
strength.
Reversible IR in hibernating animals has been hypothesized
previously (Martin, 2008). Indeed, obese autumn marmots were
reported to be hyperinsulinemic and insulin insensitive while
becoming insulin responsive in hibernation (Florant et al., 1985).
This is in stark contrast to bears, as ourwork demonstrates selec-
tive and reversible insulin intolerance during hibernation without
an increase in circulating insulin. However, we agree with the
stated hypothesis that factors other than adiposity contribute to
insulin resistance in hibernating animals (Florant et al., 1985).
Recent work in Japanese black bears (Ursus thibetanus japon-
icas) suggesting a switch to peripheral insulin resistance upon
entering hibernation is consistent with our data (Kamine et al.,
2012).Ourwork uniquely describes three states of insulin respon-
siveness and bolsters previous studies with the use of seasonal
ITT, serum, histological, and molecular analyses to put forth a
physiological argument for reversible insulin resistancemediated
by PTEN/AKT in regulating adipose tissue lipolysis.
Our data show that grizzly bears modulate insulin responsive-
ness in adipose tissue by controlling insulin signaling intensity.
Obese bears in October are remarkably insulin sensitive, with
concomitant increases in inactive and active forms of PTEN
(Vazquez et al., 2000) and AKT (Fayard et al., 2010), respectively.
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Figure 1. Grizzly Bears Control Adipose Tissue Insulin Signaling in a Seasonal Tripartite Manner
(A–C) Lysates from fasted bear biopsies analyzed by multiplex phosphoprotein signaling array and reported as mean fluorescence intensity (MFI). The lysates
used were adipose tissue (n = 6) (A), liver (n = 3) (B), and gastrocnemius (n = 6) (C). Statistical determinations were made using two-way ANOVA (*p < 0.05,
**p < 0.01, ***p < 0.001, ****p < 0.0001). Black, red, and gray asterisks indicate statistical differences compared to October, January, and May, respectively.
(D) Adipose tissue lysates from tissues biopsied pre (time 0)- and post (time 15 min) insulin injection from hibernating (n = 3, upper graph, red) and awake (n = 4,
lower graph, gray) bears. Statistical determinations were made using multiple, unpaired t tests (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001). Analytes
reported are phosphorylated forms of Akt (S473), GSK3a (S21), GSK3b (S9), IGF1R (Y1135/1136), IR (Y1162/1163), IRS1 (S312), PTEN (S380), RPS6 (S235/236),
TSC2 (S939), mTOR (S2448), and p70S6K (T412). All error bars are ± SEM.
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Seasonal Insulin Responsiveness in BearsSince neither circannual serum insulin nor activity levels change,
the intriguing possibility of a reversible, adipocyte-specific, cell-
autonomous PTEN/AKT modifying factor must be considered.
Notably, hyperactivation of adipose AKT signaling in humans
with PTEN haploinsufficiency results in a similar phenotype
observed in grizzly bears: obesity coupled with increased insulin
sensitivity (Pal et al., 2012). Our results support the notion
that adipose tissue may govern insulin sensitivity in the fasting
state (Pal et al., 2012) and that adipose tissue is exquisitely
sensitized to insulin (Karpe and Tan, 2005). Isolation of the fac-
tor(s) mediating adipose tissue insulin hypersensitivity in grizzly
bears could provide invaluable insight toward the development
of new human therapies.378 Cell Metabolism 20, 376–382, August 5, 2014 ª2014 Elsevier IncThe link between obesity and insulin resistance in humans is
difficult to understand in that, evolutionarily, fat storage should
be advantageous. However, with the hyperinsulinemia that typi-
cally accompanies human obesity, hypertrophic adipocytes
would have impaired lipolytic ability and be unable to mobilize
stored triglycerides. This would lead to a feedforward system
of adipocyte ‘‘bursting’’ (Medina-Gomez et al., 2007) and lipid
spillover (Unger and Scherer, 2010), inflammation (van Greeven-
broek et al., 2013), insulin resistance (Shoelson et al., 2006), and
increased insulin secretion. We propose that through mainte-
nance of normoinsulinemia, obese and IR bears do not undergo
these alterations. Further, since insulin intolerance is associated
with lipolysis and not hyperglycemia, we conclude that bears.
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Figure 2. Grizzly Bears undergo Reversible Insulin Resistance
(A) Seasonal serum insulin levels (n = 10).
(B) Insulin signaling was induced in human preadipocyte cultures by grizzly bear serum and analyzed by multiplex phosphoprotein signaling array (MFI, mean
fluorescence intensity; n = 6). Statistical analyses were done using multiple unpaired t tests (*p < 0.05, **p < 0.01 for all bear serum and insulin control compared
to PBS).
(C) Seasonal serum glucose levels (n = 6).
(D) Insulin tolerance tests (ITT, n = 6). Statistical analyses were done using multiple unpaired t tests (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 compared to
the May time point). The October ITT was terminated after 30 min, as all bears were administered dextrose to counteract severe hypoglycemia.
(E and F) Levels of serum nonesterified fatty acid (NEFA) (E) and adiponectin (F) (n = 6). Statistical analysis was done by one-way ANOVA with Tukey’s multiple
comparison posttest (**p < 0.01, ***p < 0.001). Red and gray asterisks indicate statistical differences compared to January and May, respectively. All error bars
are ± SEM.
R
ET
R
A
C
TE
D
Cell Metabolism
Seasonal Insulin Responsiveness in Bearsmediate insulin sensitivity to control utilization of fat as a fuel
source. Consistent with our findings, a high lipolytic rate is asso-
ciated with reduced insulin sensitivity in humans (Girousse et al.,
2013). Further, women exhibit a similar reversible state of IR to
mediate adipose tissue accretion and facilitate lipolysis during
pregnancy (Barbour et al., 2007).
It has been proposed, and data support the notion, that hy-
perinsulinemia, and not obesity itself, could be the culprit of
the modern-day metabolic syndrome epidemic. For instance,Celmice lacking three of four insulin alleles are resistant to diet-
induced obesity and subsequent lipid deposition and inflamma-
tion (Mehran et al., 2012). Furthermore, reducing insulin levels
in obese humans promotes weight loss without perturbing
insulin sensitivity or glycemia (Alemzadeh et al., 1998; Lustig
et al., 2006). Finally, another metabolically healthy organism,
the naked mole rat, exists with perpetually low levels of insulin
while remaining exquisitely sensitive to this hormone (Buffen-
stein and Pinto, 2009). It will be interesting to determine thel Metabolism 20, 376–382, August 5, 2014 ª2014 Elsevier Inc. 379
Figure 3. Obesity and IR in Grizzly Bears Correlate with Lipolysis and Are Not Accompanied by Overt Histological Changes
(A) Serum glycerol levels (n = 8). Statistical analysis was done by one-way ANOVAwith Tukey’smultiple comparison posttest (*p < 0.05, **p < 0.01). Black and gray
asterisks indicate statistical differences compared to October and May, respectively.
(B) Western blot of adipose tissue lysates collected in January (J) and May (M). The bear identification number is indicated on top. Antibodies against phospho-
HSL (pHSL), phospho-AKT (pAKT), FABP4, and Tubulin (Tub) were used.
(C–E) Hematoxylin and eosin (H&E) staining of skeletal muscle (C), liver (D), and adipose (E) from October (OCT), January (JAN), and May biopsies.
(F) Periodic Acid-Schiff (PAS) staining (top) and PAS staining with diastase (PAS+diastase) treatment (bottom) to remove staining of glycogen in liver.
Scale bar: 50 mm in (C), (D), and (F); 100 mm in (E).
(G) Serum from bears (n = 6) analyzed by multiplex cytokine array. Analytes reported are GM-CSF, IFN-g, IL-10, IL-15, IL-18, IL-2, IL-6, IL-7, IL-8, IP-10, KC-like,
MCP-1, and TNF-a.
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Seasonal Insulin Responsiveness in Bearseffects of hyperinsulinemia on bear adiposity, metabolic health,
and hibernation.EXPERIMENTAL PROCEDURES
Bearsweremaintained according to theBearCare andColonyHealthStandard
Operating Procedures, with all procedures approved by the Washington State
University Institutional Animal Care and Use Committee. The bears were anes-
thetizedwithdexmedetomidine (Zoetis, 6 ug/kg inMay andOctober and 3.5 ug/
kg in January) and tiletamine HCl/zolazepamHCl (Zoetis, 2.5mg/kg inMay and
October and 1.5 mg/kg in January) administered intramuscularly by air dart.380 Cell Metabolism 20, 376–382, August 5, 2014 ª2014 Elsevier IncUsing the May and October drug combinations in January did not affect insulin
responsiveness (Figure S2). Isoflurane in 100% oxygen was administered via
endotracheal tube to maintain a constant plane of anesthesia. The bears
were judged tobe in anadequateplaneof anesthesiabasedon lackof response
to the mild stimulus caused by instrumentation, lack of jaw tone, and lack of a
palpebral reflex. Peripheral venous catheters (14G, 14 cm; BD Angiocath)
were placed into the right or left jugular vein for serial blood sampling. Blood
samples were collected into red top tubes prior to challenge testing to analyze
serum chemistry and lipid profiles. All serum, except for ITT sampling, was
collected on fasting bears. For October and May, bears were fasted for 12 hr
prior to blood collection. Body weights were recorded and percent body fat
determined by bioelectrical impedance analyses (Farley and Robbins, 1994)..
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Blood glucose was assessed at baseline and every 5 min for a total of 50 min
postintravenous injection of 0.015 U/kg of insulin (Humalin- R, Eli Lilly). Blood
glucose was measured immediately using a commercial glucometer (Accu-
Chek Active, Roche Diagnostics). Serum collected at baseline and at the
glucose nadir was stored at 80C and used to verify glucometer readings.
If serum glucose fell to 45 mg/dl or lower, 50% dextrose solution was given
intravenously and the tolerance test was considered to be complete (October
sampling). For the January and May insulin challenges, gluteal subcutaneous
adipose tissue was biopsied as described below, followed by a single bolus
intravenous injection of 0.015 U/kg of insulin. At 15 min following the
insulin bolus, gluteal subcutaneous adipose tissue was once again biopsied
and immediately submerged in liquid nitrogen and stored at 80C until
analyzed.
Tissue Biopsies
Gluteal subcutaneous adipose tissue and gastrocnemius muscle were
biopsied using a 6 mm circular punch. Liver samples were obtained with
a 14G tru-cut biopsy needle (Progressive Medical International) and by ul-
trasound guidance (de Rycke et al., 1999). Each area was shaved and asep-
tically prepared for biopsy. Adipose tissue was obtained from the hindlimb
region over the gluteus muscles. Skeletal muscle samples were obtained
with the 6 mm punch via a short stab incision through the dermis over
the lateral aspect of either the left or right gastrocnemius muscle. Tissue
samples were placed in 1.5 ml sample vials, immediately submerged in
liquid nitrogen, and stored at 80C until analyzed or fixed in 10%
neutral-buffered formalin.
Analyte Measurements
Insulin (Alpco 80-INSPO-E01) and adiponectin (Millipore EZCADP63K) com-
mercial ELISAs were used. For western blot analysis, flash-frozen tissue was
pulverized with mortar and pestle and solubilized with a 1% Nonidet P40-
based buffer (Invitrogen FNN0021) supplemented with protease inhibitor
cocktail (Roche 0693132001) and 1 mM phenylmethanesulfonyl fluoride
(Sigma P7626). Standard SDS-PAGE was carried out using antibodies against
phosphorylated hormone-sensitive lipase (pHSL[Ser563], Cell Signaling Tech-
nology 4139), phosphorylated AKT (pAKT[Ser473], Cell Signaling Technology
4060), fatty acid binding protein 4 (FABP4, Cell Signaling Technology 3544),
and tubulin (Cell Signaling Technology 2148). For Luminex assays, lysates
were prepared as above and analyzed using the Milliplex MAP total and phos-
pho Akt/mTOR 11-plex (Millipore 48-611MAG and 48-612MAG). Phosphory-
lated levels of each analyte were normalized to their respective total protein
level and reported as such. For serum cytokine measurements, Milliplex
MAP Canine Cyotkine/Chemokine panel (Millipore CCYTOMAG-90K) was
used. Serum glycerol was determined by colorimetric assay (Caymen Chem-
ical 10010755).
Histology
Tissues were immediately fixed in 10% neutral-buffered formalin following
biopsy for 24 hr prior to standard paraffin embedding. Sections (5 mm)
were cut and subjected to standard hematoxylin and eosin staining.
Insulin Activity Assay
Human subcutaneous preadipocytes were obtained from ZenBio (SP-F-1)
and cultured as per the manufacturer’s protocol. Confluent cells were
serum starved overnight then stimulated with 100 nM insulin or 20% serum
from January, May, or October bears for 15 min. Lysates were prepared as
above and analyzed using Milliplex MAP total and phospho Akt/mTOR
11-plexes.
Statistical Analysis
All statistics were derived using GraphPad Prism 6 and presented as ± SEM.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and two figures and can be found with this article online at http://dx.doi.org/
10.1016/j.cmet.2014.07.008.
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